P. Neven
Impact in
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
- Equine top 5%
Papers in
- Immunology 11
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 7
- Immune Response and Inflammation 5
- Oncology 9
- Cancer Treatment and Pharmacology 2
- Co-authors
- Thierry Franck (11 shared papers)J. Delarge (7 shared papers)Didier Serteyn (7 shared papers)G. Deby‐Dupont (6 shared papers)Bernard Pirotte (6 shared papers)Ange Mouithys‐Mickalad (7 shared papers)Luc Delattre (1 shared paper)Géraldine Piel (1 shared paper)
- Journals
- Chemico-Biological Interactions (4 papers)Cancer Research (4 papers)The Breast (2 papers)Annals of Oncology (2 papers)Prostaglandins Leukotrienes and Essential Fatty Acids (2 papers)
- Partner nations
- BelgiumUnited StatesGermany
In The Last Decade
P. Neven
36 papers receiving 462 citations
Peers
Comparison fields: 5 of 98
- Molecular Medicine 64
- Equine 19
- Pharmaceutical Science 67
- Obstetrics and Gynecology 51
- Pharmacology 69
Countries citing papers authored by P. Neven
This map shows the geographic impact of P. Neven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Neven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Neven more than expected).
Fields of papers citing papers by P. Neven
This network shows the impact of papers produced by P. Neven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Neven. The network helps show where P. Neven may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Neven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 81 | |
| 2 | 2013 | 49 | |
| 3 | 2008 | 38 | |
| 4 | 2010 | 38 | |
| 5 | 1978 | 31 | |
| 6 | 2020 | 30 | |
| 7 | 2013 | 29 | |
| 8 | 2001 | 26 | |
| 9 | 2013 | 26 | |
| 10 | 2000 | 24 | |
| 11 | 2001 | 23 | |
| 12 | 2011 | 14 | |
| 13 | 2018 | 11 | |
| 14 | 2015 | 11 | |
| 15 | Effects of nimesulide and indometacin on COX-1 and COX-2: a comparative study. | 1999 | 10 |
| 16 | 2014 | 7 | |
| 17 | 1952 | 6 | |
| 18 | 2015 | 5 | |
| 19 | 2012 | 5 | |
| 20 | 1998 | 4 |
About P. Neven
P. Neven is a scholar working on Immunology, Oncology, Genetics, Cancer Research and Molecular Medicine, having authored 38 papers that have together received 491 indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers), Estrogen and related hormone effects (7 papers), Curcumin's Biomedical Applications (6 papers), Immune Response and Inflammation (5 papers), Breast Cancer Treatment Studies (4 papers), Inflammatory mediators and NSAID effects (4 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Molecular Medicine (64 citations), Equine (19 citations), Pharmaceutical Science (67 citations), Obstetrics and Gynecology (51 citations) and Pharmacology (69 citations). P. Neven has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Thierry Franck, J. Delarge, Didier Serteyn, G. Deby‐Dupont, Bernard Pirotte, Ange Mouithys‐Mickalad, Luc Delattre, Géraldine Piel, Gabriel Llabrès and Xavier de Leval. Their work appears in journals such as Chemico-Biological Interactions, Cancer Research, The Breast, Annals of Oncology and Prostaglandins Leukotrienes and Essential Fatty Acids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.